The impact of vascular resection on early postoperative outcomes after pancreaticoduodenectomy: An analysis of the American college of surgeons national surgical quality improvement program database

Annals of Surgical Oncology

Volumn 19, Issue 13, 2012, Pages 4068-4077

  Castleberry, Anthony W ^a   White, Rebekah R ^a   De La Fuente, Sebastian G ^b   Clary, Bryan M ^a   Blazer, Dan G ^a   McCann, Richard L ^a   Pappas, Theodore N ^a   Tyler, Douglas S ^a   Scarborough, John E ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; DATA BASE; FEMALE; HEALTH CARE QUALITY; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PANCREAS CANCER; PANCREATICODUODENECTOMY; POSTOPERATIVE PERIOD; RETROSPECTIVE STUDY; SURGICAL MORTALITY; SURGICAL RISK; VASCULAR SURGERY;

ADULT; AGED; COMORBIDITY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MIDDLE AGED; PANCREATIC NEOPLASMS; PANCREATICODUODENECTOMY; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; QUALITY IMPROVEMENT; RECONSTRUCTIVE SURGICAL PROCEDURES; RETROSPECTIVE STUDIES; SURVIVAL RATE; VASCULAR SURGICAL PROCEDURES;

EID: 84876490981     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-012-2585-y     Document Type: Article

References (62)

1. Alexakis N, Halloran C, Raraty M, Ghaneh P, Sutton R, Neo-ptolemos JP. Current standards of surgery for pancreatic cancer. Br J Surg. 2004;91:1410-27. (Pubitemid 39518076)
2. Glanemann M, Shi B, Liang F, et al. Surgical strategies for treatment of malignant pancreatic tumors: extended, standard or local surgery? World J Surg Oncol. 2008;6:123.
3. Hidalgo M. Pancreatic cancer. N Engl J Med. 2010;362:1605-17.
4. Katz MH, Wang H, Fleming JB, et al. Long-term survival after multidisciplinary management of resected pancreatic adenocar-cinoma. Ann Surg Oncol. 2009;16:836-47.
5. Shaib Y, Davila J, Naumann C, El-Serag H. The impact of curative intent surgery on the survival of pancreatic cancer patients: a U.S. Population-based study. Am J Gastroenterol. 2007;102:1377-82. (Pubitemid 46976285)
6. Sohn TA, Yeo CJ, Cameron JL, et al. Resected adenocarcinoma of the pancreas-616 patients: results, outcomes, and prognostic indicators. J Gastrointest Surg. 2000;4:567-79.
7. Stojadinovic A, Brooks A, Hoos A, Jaques DP, Conlon KC, Brennan MF. An evidence-based approach to the surgical management of resectable pancreatic adenocarcinoma. J Am Coll Surg. 2003;196:954-64. (Pubitemid 36676558)
8. Wagner M, Redaelli C, Lietz M, Seiler CA, Friess H, Buchler MW. Curative resection is the single most important factor determining outcome in patients with pancreatic adenocarcinoma. Br J Surg. 2004;91:586-94. (Pubitemid 38624667)
9. Evans DB, Farnell MB, Lillemoe KD, Vollmer C, Jr., Strasberg SM, Schulick RD. Surgical treatment of resectable and borderline resectable pancreas cancer: expert consensus statement. Ann Surg Oncol. 2009;16:1736-44.
10. Ghaneh P, Costello E, Neoptolemos JP. Biology and management of pancreatic cancer. Gut. 2007;56:1134-52. (Pubitemid 47123247)
11. Li D, Xie K, Wolff R, Abbruzzese JL. Pancreatic cancer. Lancet. 2004;363:1049-57. (Pubitemid 38410779)
12. Orr RK. Outcomes in pancreatic cancer surgery. Surg Clin North Am. 2010;90:219-34.
13. Wray CJ, Ahmad SA, Matthews JB, Lowy AM. Surgery for pancreatic cancer: recent controversies and current practice. Gastroenterology. 2005;128:1626-41. (Pubitemid 40692556)
14. Allema JH, Reinders ME, Van Gulik TM, et al. Portal vein resection in patients undergoing pancreatoduodenectomy for carcinoma of the pancreatic head. Br J Surg. 1994;81:1642-6. (Pubitemid 24349942)
15. Christians K, Evans DB. Pancreaticoduodenectomy and vascular resection: persistent controversy and current recommendations. Ann Surg Oncol. 2009;16:789-91.
16. Harrison LE, Klimstra DS, Brennan MF. Isolated portal vein involvement in pancreatic adenocarcinoma. A contraindication for resection? Ann Surg. 1996;224:342-7; discussion 7-9.
17. Kawada M, Kondo S, Okushiba S, Morikawa T, Katoh H. Reevaluation of the indications for radical pancreatectomy to treat pancreatic carcinoma: is portal vein infiltration a contraindication? Surg Today. 2002;32:598-601. (Pubitemid 34754264)
18. Nakao A, Harada A, Nonami T, Kaneko T, Inoue S, Takagi H. Clinical significance of portal invasion by pancreatic head carcinoma. Surgery. 1995;117:50-5.
19. Ramacciato G, Mercantini P, Petrucciani N, et al. Does portalsuperior mesenteric vein invasion still indicate irresectability for pancreatic carcinoma? Ann Surg Oncol. 2009;16:817-25.
20. RoDer JD, Stein HJ, Siewert JR. Carcinoma of the periampullary region: who benefits from portal vein resection? Am J Surg. 1996;171:170-4; discussion 4-5. (Pubitemid 126349891)
21. Sasson AR, Hoffman JP, Ross EA, Kagan SA, Pingpank JF, Eisenberg BL. En bloc resection for locally advanced cancer of the pancreas: is it worthwhile? J Gastrointest Surg. 2002;6: 147-57; discussion 57-8.
22. Shibata C, Kobari M, Tsuchiya T, et al. Pancreatectomy combined with superior mesenteric-portal vein resection for adenocarcinoma in pancreas. World J Surg. 2001;25:1002-5. (Pubitemid 32747647)
23. Tucker ON, Rela M. Controversies in the management of borderline resectable proximal pancreatic adenocarcinoma with vascular involvement. HPB Surg. 2008;2008:839503.
24. Van Geenen RC, ten Kate FJ, de Wit LT, Van Gulik TM, Obertop H, Gouma DJ. Segmental resection and wedge excision of the portal or superior mesenteric vein during pancreatoduodenec-tomy. Surgery. 2001;129:158-63.
25. Bachellier P, Nakano H, Oussoultzoglou PD, et al. Is pancreati- coduodenectomy with mesentericoportal venous resection safe and worthwhile? Am J Surg. 2001;182:120-9. (Pubitemid 32907346)
26. Capussotti L, Massucco P, Ribero D, Vigano L, Muratore A, Calgaro M. Extended lymphadenectomy and vein resection for pancreatic head cancer: outcomes and implications for therapy. Arch Surg. 2003;138:1316-22. (Pubitemid 37499388)
27. Fuhrman GM, Leach SD, Staley CA, et al. Rationale for en bloc vein resection in the treatment of pancreatic adenocarcinoma adherent to the superior mesenteric-portal vein confluence. Pancreatic Tumor Study Group. Ann Surg. 1996;223:154-62. (Pubitemid 26065208)
28. Launois B, Stasik C, Bardaxoglou E, et al. Who benefits from portal vein resection during pancreaticoduodenectomy for pancreatic cancer? World J Surg. 1999;23:926-9. (Pubitemid 29398475)
29. Takahashi S, Ogata Y, Tsuzuki T. Combined resection of the pancreas and portal vein for pancreatic cancer. Br J Surg. 1994;81:1190-3. (Pubitemid 24262953)
30. Toomey P, Hernandez J, Morton C, et al. Resection of por-tovenous structures to obtain microscopically negative margins during pancreaticoduodenectomy for pancreatic adenocarci-noma is worthwhile. Amer Surg. 2009;75:804-9; discussion 9-10.
31. Turley RS, Peterson K, Ceppa EP, et al. Vascular surgery collaboration during pancreaticoduodenectomy with vascular reconstruction. Ann Vascular Surgery. 2012;(in press).
32. Fink AS, Campbell DA, Jr., Mentzer RM, Jr., et al. The National Surgical Quality Improvement Program in non-veterans administration hospitals: initial demonstration of feasibility. Ann Surg. 2002;236:344-53; discussion 53-4.
33. Khuri SF, Daley J, Henderson W, et al. The Department of Veterans Affairs' NSQIP: the first national, validated, outcome-based, risk-adjusted, and peer-controlled program for the measurement and enhancement of the quality of surgical care. National VA Surgical Quality Improvement Program. Ann Surg. 1998;228:491-507. (Pubitemid 30194393)
34. Siriwardana HP, Siriwardena AK. Systematic review of outcome of synchronous portal-superior mesenteric vein resection during pancreatectomy for cancer. Br J Surg. 2006;93:662-73. (Pubitemid 43886017)
35. Fernandez-del Castillo C, Rattner DW, Warshaw AL. Standards for pancreatic resection in the 1990 s. Arch Surg. 1995;130: 295-9; discussion 9-300.
36. Fortner JG. Regional pancreatectomy for cancer of the pancreas, ampulla and other related sites. Jpn J Surg. 1983;13:385-94. (Pubitemid 14187972)
37. Fortner JG. Regional pancreatectomy for cancer of the pancreas, ampulla, and other related sites. Tumor staging and results. Ann Surg. 1984;199:418-25. (Pubitemid 14139877)
38. Fortner JG, Klimstra DS, Senie RT, Maclean BJ. Tumor size is the primary prognosticator for pancreatic cancer after regional pancreatectomy. Ann Surg. 1996;223:147-53. (Pubitemid 26065207)
39. Horvath KD, Chabot JA. An aggressive resectional approach to cystic neoplasms of the pancreas. Am J Surg. 1999;178:269-74.
40. Howard TJ, Villanustre N, Moore SA, et al. Efficacy of venous reconstruction in patients with adenocarcinoma of the pancreatic head. J Gastrointest Surg. 2003;7:1089-95. (Pubitemid 37524077)
41. Leach SD, Lee JE, Charnsangavej C, et al. Survival following pancreaticoduodenectomy with resection of the superior mesen-teric-portal vein confluence for adenocarcinoma of the pancreatic head. Br J Surg. 1998;85:611-7. (Pubitemid 28247531)
42. Machado MC, Penteado S, Cunha JE, et al. Pancreatic head tumors with portal vein involvement: an alternative surgical approach. Hepato- gastroenterology. 2001;48:1486-7. (Pubitemid 33010452)
43. Sindelar WF. Clinical experience with regional pancreatectomy for adenocarcinoma of the pancreas. Arch Surg. 1989;124: 127-32. (Pubitemid 19025918)
44. Tsao JI, Rossi RL, Lowell JA. Pylorus-preserving pancreatodu-odenectomy. Is it an adequate cancer operation. Arch Surg. 1994;129:405-12. (Pubitemid 24115960)
45. Tseng JF, Raut CP, Lee JE, et al. Pancreaticoduodenectomy with vascular resection: margin status and survival duration. J Gas-trointest Surg. 2004;8:935-49; discussion 49-50.
46. Wanebo HJ, Glicksman AS, Vezeridis MP, et al. Preoperative chemotherapy, radiotherapy, and surgical resection of locally advanced pancreatic cancer. Arch Surg. 2000;135:81-7; discussion 8. (Pubitemid 30043986)
47. Yeo CJ, Cameron JL, Lillemoe KD, et al. Pancreaticoduoden-ectomy for cancer of the head of the pancreas. 201 patients. Ann Surg. 1995;221:721-31; discussion 31-3.
48. Al-Haddad M, Martin JK, Nguyen J, et al. Vascular resection and reconstruction for pancreatic malignancy: a single center survival study. J Gastrointest Surg. 2007;11:1168-74.
49. Jain S, Sacchi M, Vrachnos P, Lygidakis NJ. Carcinoma of the pancreas with portal vein involvement-our experience with a modified technique of resection. Hepato-gastroenterology. 2005; 52:1596-600. (Pubitemid 41391043)
50. Kurosaki I, Hatakeyama K, Minagawa M, Sato D. Portal vein resection in surgery for cancer of biliary tract and pancreas: special reference to the relationship between the surgical outcome and site of primary tumor. J Gastrointest Surg. 2008;12:907-18.
51. Nakagohri T, Kinoshita T, Konishi M, Inoue K, Takahashi S. Survival benefits of portal vein resection for pancreatic cancer. Am J Surg. 2003;186:149-53. (Pubitemid 37289087)
52. Poon RT, Fan ST, Lo CM, et al. Pancreaticoduodenectomy with en bloc portal vein resection for pancreatic carcinoma with suspected portal vein involvement. World J Surg. 2004;28:602-8. (Pubitemid 38802799)
53. Riediger H, Makowiec F, Fischer E, Adam U, Hopt UT. Postoperative morbidity and long-term survival after pancreati coduodenectomy with superior mesenterico-portal vein resection. J Gastrointest Surg. 2006;10:1106-15. (Pubitemid 44332981)
54. Shimada K, Sano T, Sakamoto Y, Kosuge T. Clinical implications of combined portal vein resection as a palliative procedure in patients undergoing pancreaticoduodenectomy for pancreatic head carcinoma. Ann Surg Oncol. 2006;13:1569-78. (Pubitemid 44951464)
55. Zhou GW, Wu WD, Xiao WD, Li HW, Peng CH. Pancreatec-tomy combined with superior mesenteric-portal vein resection: report of 32 cases. Hepatobiliary Pancreat Dis Int. 2005;4:130-4.
56. Syin D, Woreta T, Chang DC, Cameron JL, Pronovost PJ, Makary MA. Publication bias in surgery: implications for informed consent. J Surg Res. 2007;143:88-93. (Pubitemid 47562444)
57. Rodgers M, Jobe BA, O'Rourke RW, Sheppard B, Diggs B, Hunter JG. Case volume as a predictor of inpatient mortality after esophagectomy. Arch Surg. 142(9):829-39.
58. Dimick JB, Wainess RM, Upchurch GR Jr, Iannettoni MD, Orringer MB. National trends in outcomes for esophageal resection. Ann Thorac Surg. 2005;79(1):212-6; discussion 217-8. (Pubitemid 40037473)
59. Chowdhury MM, Dagash H, Pierro A. A systematic review of the impact of volume of surgery and specialization on patient outcome. Br J Surg. 2007;94:145-61. (Pubitemid 46340392)
60. Golledge J, Wiggins JE, Callam MJ. Effect of surgical subspe-cialization on breast cancer outcome. Br J Surg. 2000;87:1420-5.
61. Hall BL, Hsiao EY, Majercik S, Hirbe M, Hamilton BH. The impact of surgeon specialization on patient mortality: examination of a continuous Herfindahl-Hirschman index. Ann Surg. 2009;249:708-16.
62. Solomon MJ, Thomas RJ, Gattellari M, Ward JE. Does type of surgeon matter in rectal cancer surgery? Evidence, guideline consensus and surgeons' views. ANZ J Surg. 2001;71:711-4. (Pubitemid 34014705)